Clinical Trial Update: Hydroxychloroquine and Chlorphenesin Carbamate in Combination With mFOLFIRINOX in Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the safety and tolerability of combining hydroxychloroquine and chlorphenesin carbamate with the mFOLFIRINOX regimen in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Folinic acid (folinic acid)
• Hydroxychloroquine (hydroxychloroquine)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• chlorphenesin carbamate (chlorphenesin carbamate)

Snippet

Sponsor: Changhoon Yoo | Conditions: Pancreatic Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING